Clinical trial
C2P - Phase III: MPowerment and Community Promise
NCT00381784 · University of North Carolina, Chapel Hill, Other · Completed
Key facts
| NCT number | NCT00381784 |
|---|---|
| Title | C2P - Phase III: MPowerment and Community Promise |
| Official title | Connect-To-Protect® Phase III: Local Evaluation of Community Promise Connect-To-Protect® Phase III: Local Evaluation of Mpowerment |
| Lead sponsor | University of North Carolina, Chapel Hill, Other |
| Collaborators | National Institute on Drug Abuse (NIDA) NIH National Institute of Mental Health (NIMH) |
| Status | Completed |
| Study type | Interventional |
| Conditions | HIV Infections |
| Intervention type | Behavioral |
| Interventions | Printed materials, Peer advocates |
| Enrollment | 15 |
| Start date | Jul 1, 2006 |
| Primary completion | Mar 1, 2011 |
| Completion | Mar 1, 2011 |
| First posted | Sep 28, 2006 |
| Last update posted | Mar 3, 2017 |
| Countries | Puerto Rico, United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: